Journal of Turgut Ozal Medical Center

Öz

-

Anahtar Kelimeler

• -

Small Cell Lung Cancer Case Admitted with Brain Metastasis After Nine Years

Öz

in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients. J Clin Oncol 1995;13(5):1215-20. 3. Teicher BA. Targets in small cell lung cancer. Biochem

Anahtar Kelimeler

• -

Kaynakça

1. American Cancer Society: Cancer Facts and Figures 2014. Atlanta, Ga: American Cancer Society, 2014. Last accessed March 26, 2014.
2. Lassen U, Osterlind K, Hansen M, et al.: Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients. J Clin Oncol 1995;13(5):1215-20.
3. Teicher BA. Targets in small cell lung cancer. Biochem Pharmacol 2014;15;87(2):211-9.
4. Hochstenbag MM, Twijnstra A, Wilmink JT, Wouters EF, ten Velde GP. Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol 2000;48:243–8.
5. Arriagada R, Le Chevalier T, Borie F, Riviere A, Chomy P, Monnet I, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 1995;87:183–90.
6. Auperin A, Arriagada R, Pignon JP, et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;341:476-484.
7. Fry WA, Menck HR, Winchester DP: The National Cancer Data Base report on lung cancer. Cancer 1996;77 (9):1947-55.
8. Hochstenbag MM, Twijnstra A, Wilmink JT, Wouters EF, ten Velde GP. Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol 2000;48:243–8.